• Trials and Research

  New Therapy Candidates Identified in Groundbreaking MS Study

  Posted by MS News Today Moderator on August 1, 2018 at 7:17 am

  MS is a chronic progressive disease caused by the rapid breakdown and insufficient regeneration of myelin — the protective covering surrounding nerve cells in the brain and spinal cord, and a recent study has revealed several new therapy candidates that block enzymes responsible for making cholesterol can promote myelin regeneration.

  Click here to read more about how this discovery could lead to new regenerative medicines capable of treating MS and other neurological diseases.

  What do you think about this news?

  replied 6 years, 4 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply